The Lancet: UK’s vaccine against SARS-CoV-2 is safe and induces an immune reaction
A phase 1/2 trial involving 1,077 healthy adults found that the vaccine induced strong antibody and T cell immune responses up to day 56 of the ongoing trial. These responses may be even greater after a second dose, according to a sub-group study of 10 participants Compared to the control group (given a meningitis vaccine),…
Details